Cargando…
Patient-Derived Tumor Organoid Rings for Histologic Characterization and High-Throughput Screening
Tumor organoids are promising tools for cancer biology investigations and pre-clinical drug screenings because they are often representative of the histology and drug responses of patients. Here, we introduce a facile protocol to overcome technical limitations by generating patient-derived tumor org...
Autores principales: | Nguyen, Huyen Thi Lam, Soragni, Alice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546514/ https://www.ncbi.nlm.nih.gov/pubmed/33043307 http://dx.doi.org/10.1016/j.xpro.2020.100056 |
Ejemplares similares
-
High-throughput drug screening of fine-needle aspiration-derived cancer organoids
por: Bergdorf, Kensey, et al.
Publicado: (2020) -
A simple high-throughput approach identifies actionable drug sensitivities in patient-derived tumor organoids
por: Phan, Nhan, et al.
Publicado: (2019) -
Personalized chordoma organoids for drug discovery studies
por: Al Shihabi, Ahmad, et al.
Publicado: (2022) -
Drug screening at single-organoid resolution via bioprinting and interferometry
por: Tebon, Peyton J., et al.
Publicado: (2023) -
Protocol for drug screening of patient-derived tumor organoids using high-content fluorescent imaging
por: Larsen, Brian M., et al.
Publicado: (2022)